2019 Sep;11(9):2073
GLP-1 also has a mild chronotropic effect, contributing 14 bpm on its own
GLP-1 stimulates the -cells to produce Insulin, blocks pancreatic -cells' glucagon release via somatostatin (96), slows down gastric emptying (131), improves peripheral glucose tolerance (132), suppresses appetite in the hypothalamus and amygdala (97), increases -cell mass, GSIS, and elicits protection from glucolipotoxicity (133) and apoptosis (134)
Your dose may need to go up as your provider titrates, but your price stays the sameno surprise increases for higher therapeutic doses
Weight & obesity research Investigated in early human obesity trials
It could broaden access to metabolic health tools, giving those who cant afford, tolerate, or qualify for prescription GLP-1s another option